Plt
Zurich, CH · 1 known investors
Develops a space-based biotechnology process to produce human tissue organoids from autologous mesenchymal stem cells in microgravity, along with custom hardware for commercial-scale organoid production. Its organoids target pharmaceutical research and testing, precision medicine, and transplantation-based therapies.